Clinical Trial Update: Phase II ABT-888 With Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase II trial evaluating veliparib (ABT-888) in combination with cyclophosphamide across ovarian and related gynecologic cancers; results were posted after stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• High-grade Serous Ovarian Carcinoma
• Ovarian Cancer
• Peritoneal Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-25